Description

With over 20 years of senior Medical Affairs leadership across top-tier pharmaceutical and biotechnology companies, I bring strategic depth and hands-on execution to every engagement.

I specialize in building and transforming Medical Affairs functions from the ground up: designing medical plans, leading go-to-market strategies, developing MSL teams, and delivering scientific communications that drive measurable impact at the intersection of science and business.

My expertise spans oncology and hematological malignancies, rare diseases, and specialty care, with a pan-European track record managing product launchesand training sales reps, Medical Advisors, Medical Directors and MSLs across markets.

A core pillar of my work is Scientific Communications — from strategy to execution. I support the development and review of promotional and non-promotional materials, market access dossiers, medical information content, infographics, clinical research documentation, and patient-facing resources. I ensure scientific accuracy, regulatory compliance, and compelling storytelling across all formats and audiences.

What sets me apart today is the integration of Artificial Intelligence into Medical Affairs — helping organizations leverage AI tools to accelerate evidence generation, optimize field medical strategy, and future-proof their medical organizations.

I work with:

Biotech and startups building their Medical Affairs function for the first time

Global pharma companies needing senior expertise for specific projects

CROs, consultancies, and agencies requiring specialized oncology and medical strategy input

International companies entering or expanding in the Spanish and European markets

Creative and medical communication agencies needing senior scientific oversight

Whether you need a strategic advisor, a medical plan architect, scientific content reviewed, or an MSL excellence program — I deliver senior-level thinking with the agility of an independent consultant.

Languages

English
Native or bilingual
Spanish
Native or bilingual
French
Conversational
German
Basic

Workplace preferences

Can work on-site

Madrid (up to 50km)

Head of European Medical Affairs,
Sr. Medical Director, Pharma&
January 2023 - January 2025 (2 years)
Ovarian and Prostate Cancer, MPNs, Multiple Myeloma, and CNS Lymphoma. First medical hire for Oncology & Haematology, establishing the company's first Medical Affairs department and core capabilities in less than three months, embedding scientific strategy into the business model and positioning Medical as a strategic partner from the outset. I was promoted twice in recognition of leadership, execution excellence, and enterprise-level impact.
• ● Architected and executed pan-European medical strategies across diverse markets, translating enterprise vision into high-impact local plans in a highly complex, fast-changing environment. In under one year, achieved full medical readiness and high-impact execution across markets, by building operational excellence frameworks that maximized ROI across scientific and educational investments.
Medical excellence Oncology & Hematology medical planning go to market market access
IDORSIA
Medical Affairs Manager | MSL Lead
January 2023 - July 2023 (6 months)
Focus: Central Nervous System Led the establishment of the MSLs function for the Spanish affiliate during the launch phase while hiring, building, and leading the MSL team (4 members) in Spain.
CLOVIS ONCOLOGY
Sr. European Medical Affairs Manager
January 2020 - January 2022 (2 years)
• ● By designing ways of working, capabilities, and interfaces—and bridging closely with the US team—I established a unified European Medical Excellence framework, significantly elevating scientific engagement quality, consistency, and strategic impact across markets.
• ● Nominated as a core member of the EU Leadership Team to align the European MSL organization with global strategy by translating deep customer insights into focused actions. This enabled faster, more coherent execution in the short term—strengthening scientific positioning and launch effectiveness—while informing medium- to long-term portfolio, development, and access strategies through high-quality medical intelligence.